Detalhe da pesquisa
1.
Preclinical characterization of the novel hepatitis C virus NS3 protease inhibitor GS-9451.
Antimicrob Agents Chemother
; 58(2): 647-53, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-23939899
2.
Novel, sulfonamide linked inhibitors of the hepatitis C virus NS3 protease.
Bioorg Med Chem Lett
; 24(3): 969-72, 2014 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-24405705
3.
Novel, potent and orally bioavailable indolizidinone-derived inhibitors of the hepatitis C virus NS3 protease.
Bioorg Med Chem Lett
; 22(2): 1095-8, 2012 Jan 15.
Artigo
Inglês
| MEDLINE | ID: mdl-22189140
4.
Discovery of GS-9451: an acid inhibitor of the hepatitis C virus NS3/4A protease.
Bioorg Med Chem Lett
; 22(7): 2629-34, 2012 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-22366653
5.
Discovery of GS-9256: a novel phosphinic acid derived inhibitor of the hepatitis C virus NS3/4A protease with potent clinical activity.
Bioorg Med Chem Lett
; 22(3): 1394-6, 2012 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-22244938
6.
Novel, potent, and orally bioavailable phosphinic acid inhibitors of the hepatitis C virus NS3 protease.
Bioorg Med Chem Lett
; 21(12): 3568-72, 2011 Jun 15.
Artigo
Inglês
| MEDLINE | ID: mdl-21601450
7.
Discovery of novel phosphonate derivatives as hepatitis C virus NS3 protease inhibitors.
Bioorg Med Chem Lett
; 19(13): 3453-7, 2009 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-19477126
8.
Preclinical characterization of the novel HCV NS3 protease inhibitor GS-9256.
Antivir Ther
; 22(5): 413-420, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28106531